Stockreport

Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF Jonathan Dickinson appointed Chief Executive Officer and Chairman of the Executive BoardEncouraging initial FDA feedback received on lacutamab regulatory pathwayLacutama [Read more]